By: Kaitlin Fallon, JD, Staff Writer for Life Science Compliance Update
Many in the compliance industry have warned about the possibility of Sunshine Act Open Payments data being used against reporting companies in potential lawsuits. Those days were thought to be far off. However, a recent class action case against Insys Therapeutics Incorporated, et al., shows that the future is now and that Open Payment data can, and will, be used against you. This article explores both the recent case and likely ramifications.